期刊文献+

类黄酮体外抗糖尿病活性及相关性质的研究 被引量:2

In vitro evaluation of flavonoids as diabetes-related inhibitors and their associated properties
原文传递
导出
摘要 目的研究类黄酮的α-葡萄糖苷酶、晚期糖基化产物(AGEs)的抑制活性,并探讨抑制活性与其性质间的相关性。方法采用紫外分光光度法和荧光法分别测定类黄酮对酶、AGEs的抑制率并计算出IC50值,推出抑制活性必需基团及数目,用HPLC法测得蛋白结合率,计算Pearson相关性。结果酶抑制活性必需基团为B环邻二酚羟基和C环α,β-不饱和酮基,AGEs抑制活性必需基团为B环邻二酚羟基;两者抑制率与必需基团数的r分别为0.820、0.767。人血清白蛋白(HSA)、糖化人血清白蛋白(G-HSA)的结合率分别与AGEs抑制率(r=0.759)和Xlog P(r=0.905)高度相关。结论α-葡萄糖苷酶和AGEs的抑制率与必需基团数高度相关,AGEs的抑制活性还与HSA的结合率高度相关,G-HSA的结合率与酯水分配系数高度相关。 OBJECTIVE To investigate the inhibition of flavonoids on α - glucosidase,AGEs formation and the correlation with their properties. METHODS UV and fluorescence method were applied to detect the inhibition and IC50 of flavonoids on α - glucosidase and AGEs formation, and their essential groups for inhibition were derived. Protein binding rate was obtained by HPLC method. Pearson similarity computation was then performed to calculate their correlations. RESULTS The adjacent phenolic hydroxyl in B ring and α, β - unsaturated ketone in C ring were the essential groups for α - glucosidase inhibition and adjacent phenolic hydroxylwas essential for AGEs inhibition, the inhibition rate was highly correlated to essential group numbers (r = 0. 820 and 0. 767 respectively). HSA and glycared HSA binding rate was highly correlated to AGEs inhibition rate ( r = 0.759 ) and XlogP( r = 0.905 ). CONCLUSION The α - glucosidase and AGEs inhibition rate is highly correlated with essential group numbers. HSA binding rate is highly correlated with AGEs inhibition rate, and the glycated ABR is highly correlated with XlogP.
出处 《华西药学杂志》 CAS CSCD 2015年第4期430-432,共3页 West China Journal of Pharmaceutical Sciences
关键词 类黄酮 糖尿病 抑制 Α-葡萄糖苷酶 晚期糖基化产物 HSA结合率 糖化HSA结合率 紫外分光光度法 荧光法 高效液相色谱法 相关性 Flavonoid Diabetes Inhibition - Glucosidase AGEs HSA binding rate glycated HSA binding rate UV Fluorescencemethod HPLC Correlation
  • 相关文献

参考文献5

二级参考文献6

  • 1张志锋 张浩 胡宇慧.均匀设计对多舌飞蓬提取工艺的研究[J].中草药,2002,33:72-72. 被引量:1
  • 2Mandal U, Pal TK. Formulation and in vitro studies of a fixed - dose combination of a bilayer matrix tablet containing metformin HC1 as sustained release and glipizide as immediate release[ J]. Drug Devel and Indust Phann, 2008, 34:305 - 313. 被引量:1
  • 3Xu DY, Zhae SP, Huang QX, et al. Effects of glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus [ J ]. Diabetes Res and Clin Pract, 2010, 88( 1 ) :71 -75. 被引量:1
  • 4Manuel GO, Jesfts FGR, Rafael VO, et al. Efficacy of glimepiride/metformin combination versus glibenclamide/met- formin in patients with uncontrolled type 2 diabetes mellitus[ J]. J Diabetes Complications, 2009, 23 (6) : 376 -379. 被引量:1
  • 5Szoke E, Gosmanov NR, Sinkin JC, et al. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia[ J]. Metab Clin and Exper,2006,55 (1) :78 -83. 被引量:1
  • 6高小平,张蔚瑜,邹文俊,苏芝,及元乔,刘忠荣.中药提取物中α-葡萄糖苷酶抑制剂的筛选[J].天然产物研究与开发,2003,15(6):536-538. 被引量:95

共引文献12

同被引文献26

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部